Irregular sleep and a weaker day-night activity contrast may flag depression relapse weeks before it happens. Could ...

The FDA has approved a supplemental new drug application for lumateperone (Caplyta, Johnson & Johnson) for the prevention of relapse in adults with schizophrenia. The label expansion was based on ...

Please provide your email address to receive an email when new articles are posted on . Among patients with first-episode psychosis, the effectiveness of antipsychotics for relapse prevention ...

Major depressive disorder is a leading cause of disability worldwide; identifying effective strategies to prevent depression relapse is crucial. This individual participant data meta-analysis ...

Stress is a key factor in psychotic relapse, and mindfulness offers stress resilience and well-being benefits. This study examined the effects of mindfulness-based intervention for psychosis (MBI-p) ...